Sibutramine does not decrease the number of 5-HT re-uptake sites in rat brain and, like fluoxetine, protects against the deficits produced by dexfenfluramine

Neuropharmacology

Volumn 39, Issue 11, 2000, Pages 2028-2035

  Cheetham, S C ^a   Viggers, J A ^a   Slater, N A ^a   Heal, D J ^a  

^a Research and Development   (United Kingdom)

Author keywords

5 HT re uptake sites; Dexfenfluramine; Fluoxetine; Rat brain; Sibutramine; 3H Paroxetine binding

Indexed keywords

DEXFENFLURAMINE; FLUOXETINE; PAROXETINE; SEROTONIN; SEROTONIN UPTAKE INHIBITOR; SIBUTRAMINE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN REGION; CONTROLLED STUDY; DRUG MECHANISM; DRUG MIXTURE; MALE; NEUROTOXICITY; NONHUMAN; PRIORITY JOURNAL; RAT; SEROTONIN UPTAKE; WEIGHT REDUCTION;

ANIMALS; APPETITE DEPRESSANTS; BRAIN; CYCLOBUTANES; DEXFENFLURAMINE; FLUOXETINE; MALE; PAROXETINE; RATS; RATS, SPRAGUE-DAWLEY; SEROTONIN AGONISTS; SEROTONIN UPTAKE INHIBITORS;

EID: 0033846225     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0028-3908(00)00032-0     Document Type: Article

References (45)

1. Appel N.M., Contrera J.F., De Souze E.B. Fenfluramine selectively and differentially decreases the density of serotonergic nerve terminals in rat brain: evidence from immunocytochemical studies. Journal of Pharmacology and Experimental Therapeutics. 249:1989;928-943.
2. Armatage P., Berry G. Statistical Methods in Medical Research. 2nd edn:1987;Blackwell, Oxford.
3. Berger U.V., Gu X.F., Azmitia E.C. The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine. European Journal of Pharmacology. 215:1992;153-160.
4. Buckett W.R., Thomas P.C., Luscombe G.P. The pharmacology of sibutramine hydrochloride (BTS 54 524), a new antidepressant which induces rapid noradrenergic down-regulation. Progress in Neuropsychopharmacology and Biological Psychiatry. 12:1988;575-584.
5. Butler S.A., Slater N.A., Prow M.R., Aspley S., Martin K.F., Heal D.J. D-Fenfluramine-induced depletion of rat brain 5-HT is prevented by fluoxetine or sibutramine pretreatment. British Journal of Pharmacology. 120:1997;350P.
6. 3H]5-HT uptake: effect of administration of various antidepressant treatments. Neuropharmacology. 32:1993;737-743.
7. 3H]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments. Neuropharmacology. 35:1996;63-70.
8. 3H-paroxetine binding sites in rat brain. Journal of Pharmacology and Toxicological Methods. 27:1992;209-216.
9. 3H]Paroxetine binding and serotonin content of rat and rabbit cortical areas, hippocampus, neostriatum, ventral mesencephalic tegmentum, and midbrain raphe nuclei region. Synapse. 9:1991;14-26.
10. Dunnett C.W. New tables for multiple comparisons with a control. Biometrics. 20:1964;482-491.
11. Dunnett C.W., Goldsmith C. When and how to do multiple comparisons. Buncher C.R., Tsay J.-Y. Statistics in the Pharmaceutical Industry. 1981;404 Marcel-Dekker, NY.
12. 3H]serotonin. Naunyn-Schmiedeberg′s Archives of Pharmacology. 345:1992;1-6.
13. Gobbi M., Mancini L., Presti M.L., Menninni T. Down-regulation of rat brain 5-HT uptake carriers after treatment with high doses of D-fenfluramine. Brain Research. 730:1996;165-172.
14. Gundlah C., Martin K.F., Heal D.J., Auerbach S.B. In vivo criteria to differentiate monoamine reuptake inhibitors from releasing agents: sibutramine is a reuptake inhibitor. Journal of Pharmacology and Experimental Therapeutics. 283:1997;581-591.
15. 3H]paroxetine binding to rat cortical membranes. European Journal of Pharmacology. 118:1985;107-114.
16. Heal D.J., Cheetham S.C., Prow M.R., Martin K.F., Buckett W.R. A comparison of the effects on central 5-HT function of sibutramine hydrochloride and other weight-modifying agents. British Journal of Pharmacology. 125:1998;301-308.
17. 1B autoreceptor blocking properties of the beta adrenoceptor antagonist (-)penbutolol. Journal of Pharmacology and Experimental Therapeutics. 265:1993;707-712.
18. 2 receptors in rat brain: an autoradiographic study. Synapse. 14:1993;324-331.
19. Jackson H.C., Needham A.M., Hutchins L.J., Mazurkiewicz S.E., Heal D.J. Comparison of the effects of sibutramine and other reuptake inhibitors on food intake in the rat. British Journal of Pharmacology. 121:1997;1758-1762.
20. Kreiss D.S., Wieland S., Lucki I. The presence of a serotonin uptake inhibitor alters pharmacological manipulations of serotonin release. Neuroscience. 52:1993;295-301.
21. 3H-serotonin by nerve terminals of raphe neurons: an autoradiographic study. Nature New Biology. 241:1973;187-189.
22. Lowry O.H., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. Journal of Biological Chemistry. 193:1951;265-275.
23. Luscombe G.P., Hopcroft R.H., Thomas P.C., Buckett W.R. The contribution of metabolites to the rapid and potent down-regulation of rat cortical β-adrenoceptors by the putative antidepressant sibutramine hydrochloride. Neuropharmacology. 28:1989;129-134.
24. Luscombe G.P., Slater N.A., Lyons M.B., Wynne R.D., Scheinbaum M.L., Buckett W.R. Effect on radiolabelled-monoamine uptake in vitro of plasma taken from healthy volunteers administered the antidepressant sibutramine HCl. Psychopharmacology. 100:1990;345-349.
25. 3H]paroxetine binding in rat brain. Journal of Neurochemistry. 50:1988;1783-1790.
26. McCann U., Hatzidimitriou G., Ridenour A., Fischer C., Yuan J., Katz J., Ricaurte G. Dexfenfluramine and serotonin neurotoxicity: further preclinical evidence that clinical caution is indicated. Journal of Pharmacology and Experimental Therapeutics. 269:1994;792-798.
27. McCann U., Yuan J., Ricaurte G.A. Fenfluramines appetite suppression and serotonin neurotoxicity are separable. European Journal of Pharmacology. 283:1995;R5-R7.
28. McCann U.D., Yuan J., Hatzidimitriou G., Ricaurte G.A. Selective serotonin reuptake inhibitors dissociate fenfluramine′s anorectic and neurotoxic effects: importance of dose, species and drug. Journal of Pharmacology and Experimental Therapeutics. 281:1997;1487-1498.
29. 3H]imipramine to rat neuronal membranes. Psychopharmacology. 89:1986;436-439.
30. Mennini T., Borroni E., Samanin R., Garattini S. Evidence of the existence of two different intraneuronal pools from which pharmacological agents can release serotonin. Neurochemistry International. 3:1981;289-294.
31. Molliver D.C., Molliver M.E. Anatomic evidence for a neurotoxic effect of (±)-fenfluramine upon serotonergic projections in the rat. Brain Research. 511:1990;165-168.
32. Munson P.J., Rodbard D. LIGAND: a versatile computerised approach for characterisation of ligand-binding systems. Analytical Biochemistry. 107:1980;220-239.
33. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates. 1986;Academic Press, London.
34. Perry K.W., Fuller R.W. Effect of fluoxetine on serotonin and dopamine concentration in microdialysis fluid from rat striatum. Life Sciences. 50:1992;1683-1690.
35. Raiteri M., Bonanno G., Vallebuona F. In vitro and in vivo effects of d-fenfluramine: no apparent relation between 5-hydroxytryptamine release and hypophagia. Journal of Pharmacology and Experimental Therapeutics. 273:1995;643-649.
36. Ricaurte G.A., Molliver M.E., Martello M.B., Katz J.L., Wilson M.A., Martello A.L. Dexfenfluramine neurotoxicity in brains of non-human primates. The Lancet. 338:1991;1487-1488.
37. Rowland N.E., Kalehua A.N., Li B.-H., Semple-Rowland S.L., Streit W.J. Loss of serotonin uptake sites and immunoreactivity in rat cortex after dexfenfluramine occur without parallel glial cell reactions. Brain Research. 621:1993;35-43.
38. Rudnick G., Wall S.C. p-Chloroamphetamine induces serotonin release through serotonin transporters. Biochemistry. 31:1992;6710-6718.
39. Ryan D.H., Kaiser P., Bray G.A. Sibutramine: a novel new agent for obesity treatment. Obesity Research. 3:1995;553S-559S.
40. Sabol K.E., Richards J.B., Seiden L.S. Fluoxetine attenuates the d, l-fenfluramine-induced increase in extracellular serotonin as measured by in vivo dialysis. Brain Research. 585:1992;421-424.
41. Samanin R., Garattini S. Neurochemical mechanism of action of anorectic drugs. Pharmacology and Toxicology. 73:1993;63-68.
42. Schuster C.R., Lewis M., Seiden L.S. Fenfluramine: neurotoxicity. Psychopharmacology Bulletin. 22:1986;148-151.
43. Westphalen R.I., Dodd P.R. New evidence for a loss of serotonergic nerve terminals in rats pretreated with D, L-fenfluramine. Pharmacology and Toxicology. 72:1993;241-255.
44. Weintraub M., Rubio A., Golik A., Byrne L., Scheinbaum M.L. Sibutramine in weight control: a dose-ranging, efficacy study. Clinical Pharmacology and Therapeutics. 50:1991;330-337.
45. Williams D.A. The comparison of several dose levels with a zero dose control. Biometrics. 28:1972;519-531.